Phase 1/2 Study of GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B Cell Lymphoma.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 24 Jun 2013
At a glance
- Drugs GCS 100 (Primary) ; Dexamethasone; Etoposide
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 25 Jan 2012 Status changed from suspended to withdrawn prior to recruitment.
- 20 May 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 12 Nov 2008 New trial record.